Answers are grounded in this paper and cite their sources.
Within the limitations of the present in vitro study, our results may act as preliminary evidence for its use in vital pulp therapy as a pulp capper. However, results need to be interpreted with caution until further clinical supporting evidence is reported.
No takes yet. Share an insight, caveat, or question.
Lozano-Guillén et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: